CAS: 1441000-45-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide REF: 3D-RHC00045CAS: 1441000-45-8 | Min. 95% | A consultar | Mar 21 Ene 25 |
 | Opiranserin REF: TM-T16399CAS: 1441000-45-8 | 98% | 907,00 €~2.337,00 € | Lun 27 Ene 25 |
![4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide](https://static.cymitquimica.com/products/3D/thumb/RHC00045.jpg)
4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide
CAS:1441000-45-8
4-Butoxy-N-[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamide (BDMOB) is a molecule that has been shown to act as a serotonin receptor …
Fórmula:
C21H34N2O5
Pureza:
Min. 95%
Peso molecular:
394.5 g/mol
Ref: 3D-RHC00045
| 25mg | 229,00 € | ||
| 250mg | 912,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Opiranserin
CAS:1441000-45-8
Opiranserin is a development as an injectable agent for the treatment of postoperative pain.
Fórmula:
C21H34N2O5
Pureza:
98%
Forma y color:
Solid
Peso molecular:
394.51
- Inhibidores
- Neurociencia
- Receptor 5-HT
- GlyT
- Ver más categorías
- GPCR / proteína G
Ref: TM-T16399
| 25mg | 1.410,00 € | ||
| 50mg | 1.851,00 € | ||
| 100mg | 2.337,00 € |
Entrega estimada en Estados Unidos, el Lunes 27 de Enero de 2025
